# EDGAR Filing Document

**Accession Number:** 0001862005
**File Stem:** 0000876661-26-000202
**Filing Date:** 2026-3
**Character Count:** 1030
**Document Hash:** 233f17b1b131cd00f0c606a362f42e9e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000876661-26-000202.hdr.sgml**: 20260304

**ACCESSION NUMBER**: 0000876661-26-000202

**CONFORMED SUBMISSION TYPE**: CERT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260304

**DATE AS OF CHANGE**: 20260304

**EFFECTIVENESS DATE**: 20260304

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AstraZeneca Finance LLC
- **CENTRAL INDEX KEY:** 0001862005
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** CERT
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40452
- **FILM NUMBER:** 26719060

**BUSINESS ADDRESS:**
- **STREET 1:** 1209 ORANGE STREET
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801
- **BUSINESS PHONE:** 1-800-677-3394

**MAIL ADDRESS:**
- **STREET 1:** 1209 ORANGE STREET
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801

### Attached PDF Documents

**Attachment 1:** `AZN31B33A36030426.pdf`

_No text found in this document._